Emergent Biosolutions EBS Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Emergent Biosolutions’s reported figures.
Based on trailing twelve months.
The official record: Emergent Biosolutions’s 10-Q, filed October 30, 2025, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's interest coverage?
- Emergent Biosolutions (EBS) reported interest coverage of 2× in Q3 2025.
- How has Emergent Biosolutions's interest coverage changed year-over-year?
- Emergent Biosolutions's interest coverage increased by 208.7% year-over-year, from -1.8× to 2×.
- What is the long-term trend for Emergent Biosolutions's interest coverage?
- Over 4 years (2020 to 2024), Emergent Biosolutions's interest coverage has grown at a -42.3% compound annual growth rate (CAGR), from 13.9× to -1.5×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.